Female pattern hair loss
Female pattern hair loss is a gradual thinning over the top of the head with a widening parting, while the front hairline usually stays in place. It is common and treatable: guidelines name topical minoxidil as the first-line medicine, and a doctor may add spironolactone, low-dose minoxidil tablets, PRP or laser.
Written by the Seoul Hair Loss editorial team and medically reviewed by a Korean Board-Certified Dermatologist (AAD International Fellow · ASLMS member). Last reviewed: .
On this page
What does female pattern hair loss look like?
The parting looks wider, the scalp shows through on top, and a ponytail feels thinner. Unlike in men, the front hairline usually stays. Doctors often grade it on the Ludwig scale, from grade I (mild) to grade III (most severe).
It is more common than many women expect. The European S3 guideline cites rates of up to 42% in women over a lifetime[1]. In a Korean survey of 4,601 women, 5.6% overall had pattern hair loss, rising with age to 11.7% in their sixties and 24.7% over 70. Mild thinning (grade I) was the most common form, and 45.2% reported a family history of baldness[2].
How is female pattern hair loss different from shedding?
Pattern thinning and shedding in women
Onset
- Female pattern hair loss
- Gradual, over years
- Shedding (telogen effluvium)
- Sudden, a few months after a trigger
Where
- Female pattern hair loss
- Top of the head and the parting
- Shedding (telogen effluvium)
- All over the scalp
Hairs left behind
- Female pattern hair loss
- Thinner, shorter hairs mixed with normal ones
- Shedding (telogen effluvium)
- Normal thickness
Course
- Female pattern hair loss
- Continues without treatment
- Shedding (telogen effluvium)
- Acute cases usually recover within six to nine months; some shedding persists or recurs
The two often overlap: a bout of shedding can make pattern thinning visible for the first time. Common triggers in women include childbirth, stopping birth-control pills, rapid weight loss and high fever, according to the American Academy of Dermatology (checked 2026-10-18). After giving birth, shedding tends to start about two months later and peak at about four months.
Which tests help women with hair loss?
Trichoscopy shows whether hairs are shrinking, as in pattern loss, or simply shedding. Blood tests look for causes that add to thinning. In a Seoul National University study, women with pattern hair loss had lower average ferritin (iron stores) than healthy women, 49 versus 78 µg/L, with the clearest difference before menopause[3]. Thyroid tests are common, and hormone tests are added for irregular periods, acne or extra facial hair, which can point to raised androgens.
Which treatments work for female pattern hair loss?
Treatment options for women and their evidence
Minoxidil solution or foam
- People
- —
- ResultEvidence
- First-line in the Japanese guideline; 5% foam once a day matched 2% solution twice a day over 24 weeks
- Points to know
- Foam caused less itch and dandruff than the solution
Spironolactone
- People
- 553 women among 618 patients
- ResultEvidence
- A systematic review of seven studies (553 women among 618 patients) found benefit, more so with minoxidil
- Points to know
- As a tablet, menstrual changes were reported (11.85% in a meta-analysis); not for pregnancy. On the scalp, fewer side effects
Low-dose minoxidil tablets
- People
- 1,404 patients (943 women)
- ResultEvidence
- Used by dermatologists for women, but the study cited here, a retrospective study of 1,404 patients (943 women), assessed safety rather than benefit
- Points to know
- In that study, extra facial or body hair was the most frequent effect (15.1%); no life-threatening effects were seen
- ResultEvidence
- A meta-analysis of seven studies in women found higher terminal hair density
- Points to know
- No significant difference in hair thickness; no major side effects reported
- ResultEvidence
- Over 26 weeks, about 20 more terminal hairs per cm² in women, against about 3 with a sham device
- Points to know
- Designed for home use
- ResultEvidence
- Contraindicated for female pattern hair loss in the Japanese guideline; the NHS says women should not use finasteride
- Points to know
- Some dermatologists prescribe them off-label for selected women; never in pregnancy, because they may cause birth defects
Sources for the table: Japanese guideline[4], minoxidil foam[5], spironolactone[6], spironolactone tablets[7], minoxidil tablets[8], PRP in women[9], laser comb[10], the NHS and the AAD page on female pattern hair loss (both checked 2026-10-18). The licensing status of minoxidil tablets is explained in hair loss medicines.
What about pregnancy and breastfeeding?
The American Academy of Dermatology advises that prescription hair loss tablets are not an option during pregnancy or when planning one, and that minoxidil should be avoided during pregnancy and breastfeeding. Tell the doctor about any plans for children before a prescription is written. Shedding after childbirth usually recovers by itself, and treatment for pattern thinning can be planned once breastfeeding ends.
How long before treatment shows results?
The trials in women measured results at 24 to 26 weeks[5][10]. Plan to judge a new treatment after about six months, using photos of the parting taken the same way each time.
Can women use the same hair loss medicines as men?
Partly. Minoxidil is used by both sexes. The Japanese guideline lists finasteride and dutasteride as contraindicated for female pattern hair loss[4]. Some dermatologists prescribe them off-label for selected women, and they must not be taken during pregnancy.
Will iron tablets help my hair?
Only if your iron stores are low, which a ferritin blood test shows. The Korean study suggests checking iron status early in women with hair loss[3]; the doctor then decides whether and how to treat it.
Is hair loss after stopping the pill normal?
It can be. The American Academy of Dermatology lists stopping birth-control pills among the triggers of temporary shedding, which usually settles within six to nine months.
References
Bibliographic records retrieved from PubMed (U.S. National Library of Medicine).
What does female pattern hair loss look like?
- Kanti V, Messenger A, Dobos G, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. J Eur Acad Dermatol Venereol. 2018;32(1):11-22. PubMed: 29178529
- Paik JH, Yoon JB, Sim WY, et al. The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol. 2001;145(1):95-9. PubMed: 11453914
Which tests help women with hair loss?
- Park SY, Na SY, Kim JH, et al. Iron plays a certain role in patterned hair loss. J Korean Med Sci. 2013;28(6):934-8. PubMed: 23772161
Which treatments work for female pattern hair loss?
- Manabe M, Tsuboi R, Itami S, et al. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. J Dermatol. 2018;45(9):1031-1043. PubMed: 29863806
- Blume-Peytavi U, Hillmann K, Dietz E, et al. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol. 2011;65(6):1126-1134.e2. PubMed: 21700360
- Wang C, Du Y, Bi L, et al. The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review. Clin Cosmet Investig Dermatol. 2023;16:603-612. PubMed: 36923692
- Aleissa M. The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis. Cureus. 2023;15(8):e43559. PubMed: 37719557
- Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, et al. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651. PubMed: 33639244
- de Oliveira AFQ, Arcanjo FPN, Rodrigues MRP, et al. Use of autologous platelet-rich plasma in androgenetic alopecia in women: a systematic review and meta-analysis. J Dermatolog Treat. 2023;34(1):2138692. PubMed: 36264022
- Jimenez JJ, Wikramanayake TC, Bergfeld W, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol. 2014;15(2):115-27. PubMed: 24474647